Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016)
Amarin Corp Plcuk (AMRN) posted quarterly Current Deferred Tax Assets of $900000.0 for Q4 2016, up 200.0% YoY from $300000.0 in Q1 2016, and up 200.0% sequentially from -$900000.0 in Q4 2015.
Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends
Amarin Corp Plcuk has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $900000.0 for Q4 2016.
- In Q4 2016, Current Deferred Tax Assets rose 200.0% year-over-year to $900000.0; the TTM figure through Dec 2016 stood at $900000.0 (up 200.0% YoY), while the FY2016 annual figure was $900000.0, up 200.0% from the prior year.
- Current Deferred Tax Assets advanced to $900000.0 in Q4 2016, from -$900000.0 in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for AMRN reached as high as $937000.0 in Q4 2012 and fell as low as -$900000.0 in Q4 2015.
- The 5-year median for Current Deferred Tax Assets is $900000.0 (2016), against an average of $645000.0.
- Annual changes were most pronounced in 2015 — Current Deferred Tax Assets plunged 196.36% — and 2016, when it jumped 200.0%.
- A 5-year view of Current Deferred Tax Assets shows it stood at $937000.0 in 2012, then tumbled by 49.73% to $471000.0 in 2013, then surged by 98.3% to $934000.0 in 2014, then sank by 196.36% to -$900000.0 in 2015, then jumped by 200.0% to $900000.0 in 2016.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $900000.0, -$900000.0, and $934000.0 for Q4 2016, Q4 2015, and Q3 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 900,000.00 |
| Dec 31, 2016 | 900,000.00 |
| Dec 31, 2015 | -900,000.00 |
| Dec 31, 2015 | -900,000.00 |
| Sep 30, 2015 | 934,000.00 |
| Sep 30, 2015 | 934,000.00 |
| Jun 30, 2015 | 934,000.00 |
| Jun 30, 2015 | 934,000.00 |
| Mar 31, 2015 | 934,000.00 |
| Mar 31, 2015 | 934,000.00 |
| Dec 31, 2014 | 934,000.00 |
| Dec 31, 2014 | 934,000.00 |
| Sep 30, 2014 | 471,000.00 |
| Sep 30, 2014 | 471,000.00 |
| Jun 30, 2014 | 471,000.00 |
| Jun 30, 2014 | 471,000.00 |
| Mar 31, 2014 | 471,000.00 |
| Mar 31, 2014 | 471,000.00 |
| Dec 31, 2013 | 471,000.00 |
| Dec 31, 2013 | 471,000.00 |